| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 02/09/2006 | US20060030524 Treatment of systemic lupus erythematosus by down-regulating the autoimmune response to autoantigens |
| 02/09/2006 | US20060030046 Polypeptide of given sequence; improved efficiency by using heparin binding domain derived from fibronectin; replication deficient vector |
| 02/09/2006 | US20060030045 Antisense modulation of c/ebp beta expression |
| 02/09/2006 | US20060030041 Multipotent adult stem cells and methods for isolation |
| 02/09/2006 | US20060030000 Growth factor binding constructs materials and methods |
| 02/09/2006 | US20060029998 Codes with nucleic acids; antiinflammatory agents; immunomodulation |
| 02/09/2006 | US20060029989 Targeting cells having Mad2 mutation for treatment and/or prevention of disease |
| 02/09/2006 | US20060029931 Small, interfering RNA (siRNA) molecules which inhibit expression of HALP (HIV-Associated Life Preserver) protein cloned into a plasmid or retroviral vector for introduction into host cells; screening HIV-modulating componds which prevent apoptosis resistance of infected cell; gene therapy |
| 02/09/2006 | US20060029655 Method for preparation of vesicles loaded with biological material and different uses thereof |
| 02/09/2006 | US20060029615 Novel recombinant T4 phage particle and uses thereof |
| 02/09/2006 | US20060029609 administering drug biological conjugates used for the diagnosis, prophylaxis, or treatment of nervous system disorders or lysosomal storage diseases; drug delivery; blood brain barriers |
| 02/09/2006 | US20060029607 Methods and compositions for modulating tumor growth |
| 02/09/2006 | US20060029605 Use of ErbB receptor ligands in treating diabetes |
| 02/09/2006 | US20060029602 secreted by human breast cancer MDA-MB-175 cells, leads to the formation of a constitutive active receptor complex and stimulates the growth of these cells in an autocrine manner |
| 02/09/2006 | US20060029598 Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions |
| 02/09/2006 | US20060029596 Administering to the tumor an adenovirus vector, overexpresses an adenovirus death protein; promoting the death of neoplastic cells; telomerase resistance; anticancer biodrugs |
| 02/09/2006 | US20060029588 Lysyl oxidase-like 1 (LOXL1) and elastogenesis |
| 02/09/2006 | US20060029584 Methods for improving cell line activity in immunoisolation devices |
| 02/09/2006 | US20060029583 Method for the genetic activation of cells and uses of said cells |
| 02/09/2006 | US20060029582 Methods of treating neoplasia with combinations of target cell-specific adenovirus and chemotherapy |
| 02/09/2006 | US20060029580 Method for treating a condition with neural progenitor cells derived from whole bone marrow |
| 02/09/2006 | DE102004034461A1 Gentherapie solider Tumore durch retrovirale, mit Arenavirus-Glykoprotein pseudotypisierte Vektoren Gene therapy of solid tumors by retroviral, with arena virus glycoprotein pseudotyped vectors |
| 02/09/2006 | CA2576093A1 Pharmaceutical compostion containing meltrin antagonist |
| 02/09/2006 | CA2575480A1 Inducible gene expression |
| 02/08/2006 | EP1624068A1 Genetic immunization with cationic lipids |
| 02/08/2006 | EP1624060A2 Control of gene expression |
| 02/08/2006 | EP1624053A1 Substances for preventing and treating autoimmune diseases |
| 02/08/2006 | EP1623990A2 Compositions and methods for the treatment of tumours |
| 02/08/2006 | EP1623989A1 Compositions and methods for the diagnosis of tumours |
| 02/08/2006 | EP1623723A2 Stable gene formulations |
| 02/08/2006 | EP1623046A2 Compositions and methods for the treatment of severe acute respiratory syndrome (sars) |
| 02/08/2006 | EP1623037A2 Improved method for producing non-pathogenic helper virus-free preparations of herpes virus amplicon vectors, the helper virus & the cells used in this method, the corresponding genetic tools, as well as the applications of these non-pathogenic amplicons vectors |
| 02/08/2006 | EP1623034A2 Mechanisms of myoblast transfer in treating heart failure |
| 02/08/2006 | EP1623015A2 Dna vaccine expressing ha1 of equine-2 influenza virus |
| 02/08/2006 | EP1622673A1 System for the delivery of a biologic therapy with device monitoring and back-up |
| 02/08/2006 | EP1622638A2 Butyrylcholinesterase variant polypeptides with increased catalytic efficiency and methods of use |
| 02/08/2006 | EP1578974A4 Wound healing method and kits |
| 02/08/2006 | EP1112362B1 GENE MODIFICATION IN THE GENE FOR THE DIE G$g(b)3-SUB-UNIT OF HUMAN G-PROTEIN |
| 02/08/2006 | EP1088104B1 Methods for treating a neurological disease by determining bche genotype |
| 02/08/2006 | EP0969855B1 Novel low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 02/08/2006 | EP0812356B1 Prostate-specific membrane antigen and uses thereof |
| 02/08/2006 | CN1732018A Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 02/08/2006 | CN1732016A Modified cytokines for use in cancer therapy |
| 02/08/2006 | CN1730658A Recombinant plasmid for curing prostate gland cancer and melanoma |
| 02/08/2006 | CN1730654A Antisense oligonucleotide sequence resistant to Candida albicans infection and its uses |
| 02/08/2006 | CN1730489A Muc1 and C end active fragment mutants, their encoding gene and use thereof |
| 02/08/2006 | CN1730101A O-type foot-and-mouth disease virus poly-gene duplication defect type adenovirus active carrier vaccine and process for preparing the same |
| 02/08/2006 | CN1730100A Anti-lymphadenoma gene family specificity nucleic acid vaccine combination |
| 02/08/2006 | CN1240836C Transforming growth factor alpha HI |
| 02/08/2006 | CN1240834C LY6H gene |
| 02/08/2006 | CN1240439C Genetic switch medicine for treating tumor |
| 02/07/2006 | US6995299 Model system for Hepatitis C virus infection in humans, comprising non-human animal rendered immunologically tolerant to human hepatocytes and subsequently transplanted with human hepatocytes and infected with Hepatitis C |
| 02/07/2006 | US6995240 Treatment of inflammatory disease |
| 02/07/2006 | US6995147 Method of delaying the onset of diabetes |
| 02/07/2006 | US6995140 Peptides and polypeptides useful for regenerating the nervous system |
| 02/07/2006 | US6995133 invention describes reduced synthesis of IFN alpha 5 in livers of patients with hepatitis C in comparison to healthy livers; demonstrates importance of use of such interferon sub-types in fabricating compositions for treating viral hepatopathies |
| 02/07/2006 | US6995011 Expression vector for use as tool in gene therapy |
| 02/07/2006 | US6995010 Two different adenoviral vectors for transferring a foreign gene into cell; a recombinase and a recombinase recognition sequence as the expression control system; improve efficiency of gene therapy; transformed cell |
| 02/07/2006 | US6995006 Incubating a producer cell in a cell culture medium; wherein the producer cell is other than a KB cell, whereby greater than about 102 particles are produced from the producer cell |
| 02/07/2006 | US6994994 Of the tumor necrosis factor receptor family; given amino acid sequence; use treating diseases and disorders ameliorated or cured by decreasing the levels of ligands of the original CD40R such as autoimmune diseases |
| 02/07/2006 | US6994978 Human osteoclast derived cathepsin |
| 02/07/2006 | US6994959 which compete with DNA-binding sites of regulatory proteins which regulate t-cell activity (CD28 and cytokines), preventing transcription; analyzing immunocompetence; for treatment of autoimmune diseases |
| 02/07/2006 | US6994957 Using nucleic acid |
| 02/07/2006 | US6994858 Infecting the mixed cellular compositions with reovirus which selectively lyse the ras-mediated neoplastic cells in the mixed composition |
| 02/07/2006 | US6994857 A Therapeutic protein (e.g., a polypeptide, antibody, or peptide, or fragments and variants) fused to albumin, is sufficient to prolong the shelf-lilfe of therapeutic protein |
| 02/07/2006 | US6994856 ErbB4 receptor-specific neuregulin related ligands and uses therefor |
| 02/06/2006 | WO2006014162A2 Methods of using regenerative cells in the treatment of renal diseases and disorders |
| 02/02/2006 | WO2006012625A2 Stat3 decoy oligonucleotides and uses therefor |
| 02/02/2006 | WO2006012416A2 Specific inhibition of autoimmunity and diseases associated with autoantigens |
| 02/02/2006 | WO2006012309A1 Inducible inactivation of synaptic transmission |
| 02/02/2006 | WO2006012221A2 Target cell-specific short interfering rna and methods of use thereof |
| 02/02/2006 | WO2006011491A1 Plasmid vector, transgenic animal, method of screening drug and drug |
| 02/02/2006 | WO2006010834A1 Non-integrative and non-replicative lentivirus, preparation and uses thereof |
| 02/02/2006 | WO2006010619A1 Method for diagnosing and treating bone-related diseases |
| 02/02/2006 | WO2006010514A2 Diagnostics and therapeutics for diseases associated with dual specificity mitogen-activated protein kinase kinase 5 (map2k5) |
| 02/02/2006 | WO2006010498A2 Diagnostics and therapeutics for diseases associated with methionine aminopeptidase 2 (metap2) |
| 02/02/2006 | WO2006010496A1 Diagnostics and therapeutics for diseases associated with dipeptidase 1 (dpep1) |
| 02/02/2006 | WO2006010493A1 Diagnostics and therapeutics for diseases associated with ethanolamine kinase 1 (ek11) |
| 02/02/2006 | WO2006010376A1 Method for diagnosing and treating bone-related diseases |
| 02/02/2006 | WO2005117989A9 Drugs for the prevention or treatment of immunodeficiencies, autoimmune diseases or for the induction of immune tolerance |
| 02/02/2006 | WO2005105833A3 Novel herpes simplex viruses and uses thereof |
| 02/02/2006 | WO2005094899A8 Clusterin antisense therapy for treatment of cancer |
| 02/02/2006 | WO2005090966A3 Diagnostics and therapeutics for diseases associated with peroxisome proliferator activated receptor delta (ppard) |
| 02/02/2006 | WO2005082070A3 Compositions and methods for the systemic treatment of arthritis |
| 02/02/2006 | WO2005051413A3 Disease associated genes |
| 02/02/2006 | WO2005014775A3 Raav compositions and methods for delivery of human factor vii polypeptides and treatment of hemophilia a |
| 02/02/2006 | WO2005005626A8 Yellow fever mosquito deoxyribonucleoside kinases and its use |
| 02/02/2006 | WO2004105836A3 Intravenous delivery of polynucleotides to cells in mammalian limb |
| 02/02/2006 | WO2004100877A3 Vaccine accelerator factor (vaf) for poultry |
| 02/02/2006 | WO2004092352A3 Disruption of the reg pathway |
| 02/02/2006 | WO2004058940A3 Sirna-mediated gene silencing |
| 02/02/2006 | WO2003096967A3 Dna vaccines encoding heat shock proteins |
| 02/02/2006 | US20060026700 Tissue specific genes and gene clusters |
| 02/02/2006 | US20060025581 Novel human GABA receptor proteins and polynucleotides encoding the same |
| 02/02/2006 | US20060025429 Composition and methods for inhibiting expression of hypoxia-inducible genes |
| 02/02/2006 | US20060025374 Novel oligoribonucleotide derivatives for specific inhibition of gene expression |
| 02/02/2006 | US20060025373 Modulation of glucocorticoid receptor expression |
| 02/02/2006 | US20060025372 Antisense modulation of PTP1B expression |
| 02/02/2006 | US20060025371 Methods of inhibiting COX-2 |
| 02/02/2006 | US20060025370 Methods of inhibiting VEGF-C |